Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Glutamatergic deficits are well-established neurochemical findings in Alzheimer's disease (AD) and are thought to underlie both cognitive and behavioral symptoms of the disease. However, it is unclear whether subcortical ischemic vascular dementia (SIVD) and mixed SIVD/AD (MixD) manifest similar changes in the glutamatergic system. OBJECTIVE: To measure the immunoreactivities of NMDA receptor GluN1, GluN2A, and GluN2B subunits in SIVD and MixD. METHODS: Postmortem neocortical tissues from a cohort of well-characterized, longitudinally followed-up patients with SIVD and MixD, together with age-matched controls, were processed for immunoblotting with GluN subunit-specific antibodies. RESULTS: There was a significant reduction of GluN1 only in MixD, while significant increases of GluN2A and GluN2B were found only in SIVD. Furthermore, GluN1 loss and GluN2A/2B upregulation was associated respectively with higher Braak stages and lacunar infarct scores. CONCLUSIONS: Our data suggest that the differential alterations of GluN subunits in SIVD and MixD may result from separate, interacting disease processes, and point to the potential utility of glutamatergic approaches for pharmacotherapy.

Original publication

DOI

10.3233/JAD-141764

Type

Journal article

Journal

J Alzheimers Dis

Publication Date

2015

Volume

44

Pages

431 - 437

Keywords

Alzheimer's disease, GluN receptors, mixed dementia, neurochemistry, subcortical ischemic vascular dementia, Aged, Aged, 80 and over, Alzheimer Disease, Dementia, Vascular, Female, Follow-Up Studies, Humans, Immunoblotting, Longitudinal Studies, Male, Neocortex, Nerve Tissue Proteins, Receptors, N-Methyl-D-Aspartate, Severity of Illness Index